Kelyniam Global Past Earnings Performance
Past criteria checks 0/6
Kelyniam Global's earnings have been declining at an average annual rate of -8.8%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 5.5% per year.
Key information
-8.8%
Earnings growth rate
-4.2%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 5.5% |
Return on equity | -35.3% |
Net Margin | -8.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Kelyniam Global makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 3 | 0 | 2 | 0 |
30 Sep 23 | 3 | 0 | 2 | 0 |
31 Mar 23 | 3 | 0 | 2 | 0 |
31 Dec 22 | 3 | 0 | 2 | 0 |
30 Sep 22 | 3 | 0 | 2 | 0 |
30 Jun 22 | 3 | 0 | 2 | 0 |
31 Mar 22 | 3 | 0 | 2 | 0 |
31 Dec 21 | 3 | 0 | 2 | 0 |
30 Sep 21 | 2 | 0 | 2 | 0 |
30 Jun 21 | 2 | 0 | 1 | 0 |
31 Mar 21 | 3 | 0 | 1 | 0 |
31 Dec 20 | 3 | 0 | 1 | 0 |
30 Sep 20 | 3 | 0 | 1 | 0 |
30 Jun 20 | 3 | 0 | 1 | 0 |
31 Mar 20 | 2 | 0 | 1 | 0 |
31 Dec 19 | 2 | 0 | 1 | 0 |
31 Dec 18 | 2 | 0 | 1 | 0 |
31 Dec 17 | 2 | 0 | 1 | 0 |
31 Dec 16 | 2 | 0 | 1 | 0 |
31 Dec 15 | 1 | 0 | 1 | 0 |
31 Dec 14 | 2 | 0 | 1 | 0 |
31 Mar 14 | 2 | 0 | 1 | 0 |
31 Dec 13 | 2 | 0 | 1 | 0 |
Quality Earnings: KLYG is currently unprofitable.
Growing Profit Margin: KLYG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KLYG is unprofitable, and losses have increased over the past 5 years at a rate of 8.8% per year.
Accelerating Growth: Unable to compare KLYG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: KLYG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: KLYG has a negative Return on Equity (-35.25%), as it is currently unprofitable.